Compound ID | 1352

Update compound information

IID572

Class: Beta-lactamase inhibitor

Agent Type: Synthetic; Small molecule; Direct acting; Antibiotic adjuvant;
Spectrum of activity: Gram-positive & Gram-negative
Institute where first reported: Novartis
Highest development stage: Preclinical
Development status: Experimental
Chemical structure(s):
Click here for structure editor
Molecular weight: 299.24
Iso. SMILES: C1[C@H]2CNC(=O)[C@H]2N3C[C@@H]1N(C3=O)OS(=O)(=O)[O-].[Na+]
InChI Key: KYZNSTBCSGIMTA-YAFCINRGSA-M
Can. SMILES: C1[C@H]2CNC(=O)[C@H]2N3C[C@@H]1N(C3=O)OS(=O)(=O)[O-].[Na+]
InChI: InChI=1S/C8H11N3O6S.Na/c12-7-6-4(2-9-7)1-5-3-10(6)8(13)11(5)17-18(14,15)16;/h4-6H,1-3H2,(H,9,12)(H,14,15,16);/q;+1/p-1/t4-,5+,6-;/m0./s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/140855264
Citations:
  • https://academic.oup.com/jac/article-abstract/75/6/1530/5766087?redirectedFrom=fulltext
  • https://doi.org/10.1021/acsinfecdis.9b00031

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.